 |
 Video: What is a Stock Split?
|
|
|
| Eli Lilly and Company is engaged in discovering, developing, manufacturing, and marketing products in two business segments: human pharmaceutical products; and animal health products. Co.'s human pharmaceutical products include: cardiovascular, endocrinology, immunology, neuroscience and oncology products. Co.'s animal health products are comprised of products for animals, among others, which include Clynav™, a vaccine to control pancreas disease in salmon; Coban®, Maxiban®, and Monteban®, anticoccidial agents for use in poultry; as well as products for companion animals, which include Comfortis®, a chewable tablet that kills fleas and prevents flea infestations on dogs. According to our Lilly (Eli) and stock split history records, Lilly (Eli) and has had 4 splits. | |
|
Lilly (Eli) and (LLY) has 4 splits in our Lilly (Eli) and stock split history database. The first split for LLY took place on January 30, 1986. This was a 2 for 1
split, meaning for each share of LLY owned pre-split, the shareholder now owned 2 shares. For example, a 1000 share position pre-split, became a 2000 share position following the split. LLY's second split took place on May 01, 1989. This was a 2 for 1
split, meaning for each share of LLY owned pre-split, the shareholder now owned 2 shares. For example, a 2000 share position pre-split, became a 4000 share position following the split. LLY's third split took place on December 21, 1995. This was a 2 for 1
split, meaning for each share of LLY owned pre-split, the shareholder now owned 2 shares. For example, a 4000 share position pre-split, became a 8000 share position following the split. LLY's 4th split took place on October 16, 1997. This was a 2 for 1
split, meaning for each share of LLY owned pre-split, the shareholder now owned 2 shares. For example, a 8000 share position pre-split, became a 16000 share position following the split.
When a company such as Lilly (Eli) and splits its shares, the market capitalization before and after the split takes place remains stable, meaning the shareholder now owns more shares but each are valued at a lower price per share. Often, however, a lower priced stock on a per-share basis can attract a wider range of buyers. If that increased demand causes the share price to appreciate, then the total market capitalization rises post-split. This does not always happen, however, often depending on the underlying fundamentals of the business. Looking at the Lilly (Eli) and stock split history from start to finish, an original position size of 1000 shares would have turned into 16000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Lilly (Eli) and shares, starting with a $10,000 purchase of LLY, presented on a split-history-adjusted basis factoring in the complete Lilly (Eli) and stock split history.
Growth of $10,000.00
With Dividends Reinvested
|
| Start date: |
03/19/2009 |
|
| End date: |
03/18/2019 |
|
| Start price/share: |
$31.83 |
|
| End price/share: |
$125.24 |
|
| Starting shares: |
314.17 |
|
| Ending shares: |
457.10 |
|
| Dividends reinvested/share: |
$20.29 |
|
| Total return: |
472.48% |
|
| Average Annual Total Return: |
19.06% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$57,261.98 |
|
| Years: |
10.00 |
|
| |
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
03/19/2009 |
|
| End date: |
03/18/2019 |
|
| Start price/share: |
$31.83 |
|
| End price/share: |
$125.24 |
|
| Dividends collected/share: |
$20.29 |
|
| Total return: |
357.20% |
|
| Average Annual Total Return: |
16.41% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$45,717.63 |
|
| Years: |
10.00 |
|
|
|
| Date |
Ratio |
| 01/30/1986 | 2 for 1
| | 05/01/1989 | 2 for 1
| | 12/21/1995 | 2 for 1
| | 10/16/1997 | 2 for 1
|
|
|
